Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials
Statistical Communications in Infectious Diseases · 2020
DOI: 10.1515/scid-2019-0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Communications in Infectious Diseases, 2020. Verfasst von Elizabeth R Brown und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Reseasrch Center, 1100 Fairview Avenue North, M2-C200, Seattle, WA, 98109-1024, USA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Objectives
Using the MTN-020/ASPIRE HIV prevention trial as a motivating example, our objective is to construct a joint model for the HIV exposure process through vaginal intercourse and the time to HIV infection in a population of sexually active women. By modeling participants’ HIV infection in terms of exposures, rather than time exposed, our aim is to obtain a valid estimate of the per-act efficacy of a preventive intervention.
Methods
Within the context of HIV prevention trials, in which the frequency of sex acts is self-reported periodically by the participants, we model the exposure process of the trial participants with a non-homogeneous Poisson process. This approach allows for variability in the rate of sexual contacts between participants as well as variability in the rate of sexual contacts over time. The time to HIV infection for each participant is modeled as the time to the exposure that results in HIV infection, based on the modeled sexual contact rate. We propose an empirical Bayes approach for estimation.
Results
We report the results of a simulation study where we evaluate the performance of our proposed approach and compare it to the traditional approach of estimating the overall reduction in HIV incidence using a Proportional Hazards Cox model. The proposed approach is also illustrated with data from the MTN-020/ASPIRE trial.
Conclusions
The proposed joint modeling, along with the proposed empirical Bayes estimation approach, can provide valid estimation of the per-exposure efficacy of a preventive intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fred Hutchinson Cancer Reseasrch Center, 1100 Fairview Avenue North, M2-C200, Seattle, WA, 98109-1024, USA.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- GRAIL, Inc., Menlo Park, CA, USA.
ORCID-Profile: Clara P Dominguez Islas
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Mental Health
- U.S. National Institutes of Health
Zitieren
APA
Brown, E. R., Islas, C. P. D., & Zhang, J. (2020). Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials. Statistical Communications in Infectious Diseases. https://doi.org/10.1515/scid-2019-0016
Vancouver
Brown ER, Islas CPD, Zhang J. Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials. Statistical Communications in Infectious Diseases. 2020. doi:10.1515/scid-2019-0016
BibTeX
@article{Brown2020,
author = {Brown, Elizabeth R and Islas, Clara P Dominguez and Zhang, Jingyang},
title = {Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials},
journal = {Statistical Communications in Infectious Diseases},
year = {2020},
doi = {10.1515/scid-2019-0016}
}
EUVIMED